Established in 2020 Wednesday, October 27, 2021


Moderna Covid vaccine edges Pfizer in new US research
A nurse holds a vial of Moderna Covid-19 vaccine at Oltepesi Dispensary in Kajiado, Kenya, on September 9, 2021. Patrick Meinhardt / AFP.



WASHINGTON, DC (AFP).- A new study released by the US Centers for Disease Control and Prevention (CDC) on Friday is the latest to suggest the Moderna Covid vaccine confers better long-term protection against hospitalization than Pfizer.

CDC researchers conducted an analysis of nearly 3,689 adults who were hospitalized with severe Covid from March 11 to August 15, 2021 -- a period that precedes and includes the dominance of the Delta variant.

Overall, 12.9 percent were fully vaccinated with the Moderna vaccine, 20.0 percent were vaccinated with Pfizer-BioNTech, and 3.1 percent were vaccinated with Johnson & Johnson.

Over the entire period, the Moderna vaccine was 93 percent effective against hospitalization, Pfizer was 88 percent effective, and J&J was 68 percent effective.

The loss of efficacy against hospitalization for Pfizer was particularly pronounced: it fell from 91 percent in 14-120 days after vaccination to 77 percent more than 120 days after vaccination.

By contrast, Moderna fell from 93 percent to 92 percent when comparing the same two periods.




The study also included a separate analysis of the levels of different types of antibodies provoked by the vaccines, taken from 100 volunteers.

The Moderna vaccine elicited higher levels of antibodies compared to Pfizer and J&J for a key part of the virus' spike protein, which it uses to invade cells.

There is accumulating research suggesting the Moderna vaccine's superiority over the Pfizer vaccine, including a previous CDC studies released last week.

The reasons aren't fully clear, but it could be because the dosage levels are higher -- 100 micrograms against 30.

It could also be tied to the dosing interval, with the Pfizer shots given three weeks apart versus Moderna, which are given four weeks apart.

The Food and Drug Administration was holding a meeting of leading independent experts on Friday to weigh the question of giving third doses of Pfizer to the general population, not just immune compromised people.

© Agence France-Presse







Today's News

September 19, 2021

Ancient DNA rewrites early Japanese history-modern day populations have tripartite genetic origin

Moderna Covid vaccine edges Pfizer in new US research

Effect of electrons with negative mass in novel semiconductor nanostructures

AugLimb: A compact robotic limb to support humans during everyday activities

Lessons from how bats resist COVID could inform new treatments in humans

This is what it looks like when a black hole snacks on a star

What if just one airborne particle was enough to infect you?

Convalescent plasma doesn't help severely ill COVID-19 patients, Canadian study shows

Treating infertility with drug-delivering microspheres

How climate change could impact algae in the global ocean

Animals died in 'toxic soup' during Earth's worst mass extinction: A warning for today

Plants evolved complexity in two bursts-with a 250-million-year hiatus

Iceland's volcanic eruption the longest in half a century

Australian wildfires triggered massive algal blooms in southern ocean

The dynamic tracking of tissue-specific secretory proteins

Yeast and bacteria together biosynthesize plant hormones for weed control



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful